Trials / Completed
CompletedNCT03137433
Weight Loss With Meal-Replacement Therapy in Teens
Enhancing Weight Loss With Meal-Replacement Therapy in Teens With Severe Obesity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 13 Years – 17 Years
- Healthy volunteers
- Accepted
Summary
This study seeks to examine whether meal-replacement therapy is able to enhance weight loss among teens with severe obesity. In addition, we are also interested in examining the degree of weight loss needed to improve important cardiometabolic risk factors among adolescents.
Detailed description
This study will involve 130 adolescents (ages 13-17 years old) participating in meal replacement therapy and will last one year (12 months). Participants will be asked to strictly follow the individually-prescribed eating regimen, which will include shakes (breakfast and lunch) and pre-packaged frozen entrée meals for dinner, two servings of fruit, and three servings of vegetables per day. Daily caloric allotment will be tailored for each individual (number of shakes and frozen meals) by calculating the average daily caloric deficit necessary to achieve negative energy balance (using the metabolic rate/energy expenditure data). Shakes/meals will be provided free of charge - fruits/vegetables will be purchased by the participants. Guidance will be provided regarding the use of the meal replacement shakes at school, and participants will be encouraged to engage in family meal sessions despite eating different foods. We will measure the changes in resting metabolic rate, traditional clinical risk markers (TG, HDL-c, LDL-c, TC, glucose, insulin), vascular function, weight-related quality of life, and physical activity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Meal-replacement Therapy | We seek to examine the effect of meal-replacement therapy on weight loss outcomes in teens with severe obesity. |
Timeline
- Start date
- 2018-01-02
- Primary completion
- 2022-09-30
- Completion
- 2023-04-30
- First posted
- 2017-05-02
- Last updated
- 2024-03-22
- Results posted
- 2024-03-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03137433. Inclusion in this directory is not an endorsement.